Abstract
Medication-related osteonecrosis of the jaw (MRONJ) is a severe complication of anti-resorption drugs and anti-angiogenesis drugs. Its mechanism is still unclear, which may be related to bone remodeling inhibition, angiogenesis inhibition, inflammation, etc. The main clinical symptoms are continuous infection, recurrent swelling and pain and impacting the patients' quality of life. Because of its serious symptoms and unclear treatment, MRONJ has attracted wide attention. Now there are many researches on the treatment and prevention of MRONJ. The treatment includes conservative treatment and surgical treatment. There is no clear evidence of the effectiveness of existing methods of prevention and treatment of MRONJ, and lacking the unified and accepted standard methods of prevention and treatment. In this article, current researches of the prevention and treatment of MRONJ are reviewed, including the mechanism of the methods.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
